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5Vascular Surgery, J.W. Goethe-University Frankfurt am Main, Frankfurt am Main, GermanyObjective. There is growing evidence that, in high-grade internal carotid artery (ICA) stenosis, continuous fibrous cap
thinning is not mandatory for plaque rupture and symptom development. The possibility that smooth muscle cell (SMC)
apoptosis is involved in loss of fibrous cap volume has only been examined in a limited number of patients with high grade
carotid artery stenosis.
Methods. Endarterectomy specimens from nZ38 consecutive patients undergoing surgery for high-grade ICA stenosis
(R70%) were transversely sectioned at 2 mm intervals. Plaque instability was defined clinically, by a history of recent
ischemic symptoms (!60 days before surgery; nZ19) attributable to the stenosis, or histopathologically by the presence of
plaque rupture (nZ14). Detailed morphometric analyses of the fibrous cap was based on routine stains; for DNA in situ end
labeling the TUNEL technique was used. SMCs were identified by immunostaining for SMC actin.
Results. We found no significant difference between symptomatic/asymptomatic or ruptured/unruptured plaque with
respect to various morphometric measures of the fibrous cap (i.e. mean area, number of plaque sections with fibrous cap,
necrotic core-to-lumen distance at its thinnest or thickest part). The mean (GSD) apoptotic SMCs per thousand within the
fibrous cap was significantly higher in symptomatic vs. asymptomatic (64.53G77.3 vs. 6.71G11.9; P!0.001) but not in
ruptured plaques (43.3G64.4 vs. 30.1G60.9; PZ0.117).
Conclusions. These data suggest that continuous thinning of the fibrous cap is not an essential prerequisite for plaque
rupture in ICA stenosis. Symptomatic, but not ruptured plaque, were associated with the highest number of apoptotic SMC.
Thus, it seems unlikely that SMC apoptosis promotes plaque rupture by fibrous cap thinning.Keywords: Apoptosis; Atherosclerosis; Carotid arteries; Stenosis.Introduction
In advanced atherosclerotic lesions, including those in
the carotid territory, plaque rupture has been ident-
ified as one key event leading to intraluminal
thrombus formation and symptom development.1–4
Different mechanisms may contribute to focal weak-
ening of the fibrous cap, making the plaque more
vulnerable to rupture. A high degree of inflammatory
cell infiltration may be associated with an increased
local concentration of activated matrix degrading
enzymes.5,6 Additionally, in symptomatic carotiding author. Dr Frank Trostdorf MD, Department of
W. Goethe-University Frankfurt am Main, Schleusen-
28 Frankfurt/Main, Germany.
: f.trostdorf@em.uni-frankfurt.de
0528+ 08 $35.00/0 q 2004 Elsevier Ltd. All rights reserplaque abnormal neovessels are more frequent com-
pared to asymptomatic plaque.7,8 Furthermore, an
increased rate of smooth muscle cell (SMC) apoptosis
has been linked to plaque instability, suggesting that a
loss of cellularity of the fibrous cap via apoptosis may
reduce the content of matrix substances (i.e. collagen),
and thereby weaken the mechanical stability.9–11
For high-grade carotid artery stenosis, it has been
suggested that the fibrous cap may be thinner in
symptomatic than in asymptomatic patients as
measured by in vivo ultrasonic or magnetic resonance
imaging techniques.12,13 Nevertheless, validation
studies for these techniques revealed only moderate
to good agreement with histological reference stan-
dards (kappa values ranging from 0.5 to 0.85).12,13 One
histological study suggested a higher percentage of
focal thinning of the fibrous cap in patients with aEur J Vasc Endovasc Surg 29, 528–535 (2005)
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found no significant reduction of total fibrous cap area
in symptomatic patients.14 The relationship between
fibrous cap morphology and plaque rupture has not
been evaluated before. Therefore, the purpose of the
present investigation was to assess fibrous cap
morphology in detail and elucidate the potential
impact of SMC apoptosis on fibrous cap thinning
and loss of SMC cellularity with respect to clinical and
morphologic features of plaque instability (i.e.
ischemic symptoms and plaque rupture) in high-
grade carotid artery stenosis.MethodsPatients
This prospective study included 38 consecutive
surgical patients, scheduled to undergo carotid endar-
terectomy for extracranial high-grade ICA stenosis
(R70% luminal narrowing). The study was approved
by the ethics review committee of the University
hospital of Frankfurt. All patients gave written
informed consent. Baseline characteristics of the
study population are provided in Table 1. The degree
of luminal narrowing was determined by intra-arterial
cerebral angiography, using the criteria of the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET).15 Patients were defined as symptomatic if
they had recently (!60 days before) experienced
transient retinal or cerebral symptoms or minor
ischemic strokes attributable to the high-grade ICA
stenosis.15 Patients were defined as asymptomatic if
they had no history of cerebral ischemia. RoutineTable 1. Clinical features of asymptomatic and symptomatic patients
Asymptomatic (nZ19)
Age (mean G SD) (yrs) 68G8
Male sex (%) 79
Luminal narrowing (meanGSD), % 85G8
Time elapsed since last ischemic symptom
!30 days (%)
30–60 days (%)
Risk factors
Arterial hypertension (%) 68
Smoking (%) 58
Diabetes (%) 37
Hypercholesterolemia* (%) 32
Current medication
Antihypertensives (%) 53
Lipid lowering drugs (%) 21
Oral anticoagulants† (%) 5
Antiaggregates† (%) 63
* Low density lipoprotein cholesterolO160 mg/dl, fasten.
† Application was routinely stopped at least 6 days before surgery.cardiological and medical assessment performed pre-
operatively did not reveal possible sources of cardiac
embolism or systemic infectious disease.
Presurgical medical treatment was similar between
both groups of patients with respect to use of
antihypertensive, lipid lowering, and antithrombotic
agents (Table 1). Antiplatelet medication and oral
anticoagulants were routinely stopped at least 6 days
before surgery. On the day of surgery, routine
coagulation parameters were normal in all patients.
The patients received anticoagulation with 100 IE
Heparin/kg bodyweight 5 min before clamping. This
was antagonized with 50 U of protamin/kg body-
weight 10 min after declamping.Histological procedures, immunostaining and DNA in situ
end labeling
All carotid plaques were excised en block (routine
endarterectomy). In the majority of surgical pro-
cedures (nZ30), the eversion technique was used, by
which the residual lumen was not incised (see Fig. 1);
in the remaining eight cases longitudinal arteriotomy
was performed. Thereafter, the plaque was rinsed in
saline, immediately fixed in 4% formalin, decalcified,
and transversely sectioned at 2 mm intervals.2,16,17
Each 2 mm tissue block was embedded separately into
paraffin. The quantitative analysis was based on all
blocks derived from each individual plaque. The mean
number (GSD) of blocks examined per plaque was
7.6G3.7. The total number of blocks examined was
288. From each block serial 3 mm sections were
obtained. From all sections, an Elastic van Gieson
(EvG)- and a hematoxylin/eosin (HE)-stain was
performed for routine microscopic analysis.with high-grade ICA stenosis
Symptomatic (nZ19)
63G10
63
80G9
79
21
58
53
26
37
58
16
11
68
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Fig. 1. Illustrations of a ruptured (A) and unruptured (B) plaque are shown in (A) and (B). Plaque rupture was generally
defined as an intimal defect larger than 1000 mm in width, exposing the necrotic core of the atheromateous plaque. Original
magnification!40.
F. Trostdorf et al.530For immunohistochemical staining, we used pri-
mary monoclonal antibodies against smooth muscle
cell actin (a-SMC, DAKO, Denmark). Sections were
incubated with the primary antibody diluted 1/200
followed by biotinylated secondary antibody (Amer-
sham Life Sciences) and an avidin and biotinylated
horseradish peroxidase macromolecular complex
(Vectastain ABC kit) was visualized with 3,3 dia-
mino-benzidine (DAB).
Adjacent tissue sections were used for DNA in situ
end labeling. After deparaffinization and rehydration,
tissue sections were incubated with 3% citric acid for
elimination of free calcium and pretreated with
proteinase K (20 mg/ml, Roche Diagnostics, Man-
nheim, Germany) and 3% H2O2 for 15 min each. For
DNA end labeling, the TUNEL technique (ApopTag in
situ Apoptosis Detection Kit, Intergen) was used
according to the manufacturer’s protocol with minor
modifications. In brief, the sections were incubated
with TdT enzyme labeling mix for 90 min in a humid
chamber at 37 8C. Incorporated digoxigenin was
visualizid with anti-digoxigenin-peroxidase antibody
(Fab fragments, Roche Diagnostics, Mannheim,
Germany) and DAB. Negative controls were incubated
with PBS instead of TdT emzyme. Lymphoma tissue
was used for positive controls. For identification of
apoptotic SMCs, the TUNEL technique was combined
with periodic acid-Schiff (PAS) stain, as described
previously (Fig. 2).10 TUNEL-stained nuclei fulfilling
morphological criteria of apoptosis (cell shrinkage,
apoptotic bodies) surrounded by PAS-positive basal
lamina were identified as SMCs undergoing apoptosis.
Identification was confirmed by immunohistochem-
ical staining of SMCs and PAS stain at adjacent
sections as described above (Fig. 3).Eur J Vasc Endovasc Surg Vol 29, May 2005Quantification of SMC apoptosis, plaque morphometry and
plaque rupture
All adjacent stained plaque sections were digitized
(analySIS, Soft Imaging System, Muenster, Germany)
at 40! magnification. The total number of apoptotic
SMCs within each plaque section and within the
fibrous cap were counted. Additionally, the total
number of SMCs within 1 mm2 at three representative
areas of the fibrous cap (both shoulder regions and
mid part) were counted for each plaque section.
Thereafter, total plaque area (mm2), the number of
plaque sections revealing morphologic features of the
fibrous cap, the mean area of the fibrous cap above the
necrotic core (mm2) averaged across these plaque
sections, the minimal distance between the necrotic
core and the vessel lumen (mm) from the plaque
section with the thinnest part and the averagemaximal
necrotic core-to-lumen distance (mm) of the fibrous
cap were derived from HE- or EvG-stained sections,
respectively (see Fig. 2(A) and (B)). Plaque rupture
was defined as an intimal defect larger than 1000 mm in
width, exposing the necrotic core of the atheromateous
plaque (see Fig. 1).2 All morphometric measures were
obtained independently by two examiners (FT, MK),
values reported are means of the two observer
measurements.Statistical Analyses
Quantitative measures were compared using nonpara-
metric Mann–Whitney U test. Because we performed
consecutive statistical tests, a-adjustment according to
the modified Bonferroni procedure was applied.
Fig. 2. Cross-sections of unruptured (A) and ruptured (B) carotid endarterectomy specimen showing pathoanatomic features
of advanced atherosclerotic lesions (i.e. necrotic core, *; fibrous cap, yellow line; residual lumen, L). Blue dots indicate the
location of apoptotic SMCs. Determination of the minimal and maximal distance between the necrotic core and the vessel
lumen at the thinnest or thickest part of the fibrous cap is illustrated in the schematic figures. Original magnification !20.
(For interpretation of the references to colour in this figure legend, refer to the web version of this article).
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correlation. All quantitative analyses were performed
blinded to clinical data.ResultsFibrous cap morphometry
The different quantitative measures of fibrous cap
morphology, with respect to clinical instability or
morphological features of plaque rupture, are given in
Table 2. Overall, there was no significant difference
between groups for any of these measures, indicating
that there was no obvious morphological difference ofthe fibrous cap between symptomatic/asymptomatic
or ruptured/unruptured plaque, respectively.Smooth muscle cell apoptosis
Apoptosis of SMCs was a rare finding within the
advanced atherosclerotic lesions. Overall, apoptotic
SMC bodies were present in 169 of 288 slices (58%) and
were almost exclusively located within the fibrous cap
(see Fig. 2(A) and (B)). The total number of SMC
apoptotic bodies per plaque, the mean number of
apoptotic SMCs per total plaque area, the mean
number of apoptotic SMCs per fibrous cap area and
the number of apoptotic SMCs per thousand ‘vital’
SMCs were significantly higher in the symptomatic
group than the asymptomatic group (Table 3).Eur J Vasc Endovasc Surg Vol 29, May 2005
Fig. 2 (continued )
F. Trostdorf et al.532Furthermore, there was a trend towards higher values
of apoptotic SMCs in ruptured vs. unruptured plaque,
but after a-adjustment, this trends did not reach
statistical significance (Table 3). Furthermore, there
was no significant difference in the mean number of
SMCs per mm2 fibrous cap area, indicating no loss of
SMC cellularity in symptomatic or ruptured plaque
(Table 3). There was no correlation between the total
number of apoptotic SMCs within the fibrous cap and
the corresponding mean number of ‘vital’ SMCs per
mm2 fibrous cap (correlation coefficient, 0.216; pZ
0.213). There was no correlation between the mean
number of apoptotic SMC per mm2 fibrous cap and the
corresponding mean fibrous cap area (correlation
coefficient, K0.148; pZ0.389) or the mean number of
apoptotic SMC per mm2 fibrous cap and the minimal
necrotic core-to-lumen-distance (correlation coeffi-
cient, 0.184; pZ0.283).Eur J Vasc Endovasc Surg Vol 29, May 2005Discussion
One major finding of the present study was that we
could not find any significant differences in fibrous cap
morphometry between symptomatic and asympto-
matic carotid plaque (Table 2). Partially, this is in
contrast to previous reports. Carr et al. reported a
higher rate of ‘fibrous cap thinning’ in symptomatic
(95%) vs. asymptomatic carotid plaques (48%; pZ
0.003).3 Unfortunately, they did not define ‘fibrous cap
thinning’ in detail. Dhume et al. found that the average
maximal diameter of fibrous cap was significantly
lower in symptomatic (0.035G0.003 mm) compared to
asymptomatic carotid plaque (0.129G0.01 mm; p!
0.001).14 However, the fibrous cap diameter may not be
capable of indicating loss of fibrous cap volume. On
the other hand, these authors did not find a significant
difference in total fibrous cap area (0.027G0.001 vs.
Fig. 3. TUNEL-positive nucleus within the fibrous cap of the plaque (A). Expression of a-actin (B) und detection of thickened
PAS-positive basal laminae (C), indicating smooth muscle cell origin. Original magnification !100.
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symptomatic plaque revealed a larger necrotic core
which was covered by a larger, thinner fibrous cap, so
that the average area of the fibrous cap appeared to be
nearly the same for symptomatic and asymptomatic
plaques.14 Nevertheless, in the present sample we did
not find a significant difference in the average maximalTable 2. Relationships between different morphometric measures of
specimens, respectively
Asympt. (nZ19) Sympt. (nZ19)
Mean number of
plaque sections with
fibrous cap, n
6.0 (2.0–13.0) 6.0 (2.0–20.0)
Mean area of fibrous
cap (mm2)
2.64 (1.54–4.75) 2.22 (1.58–5.36)
Minimal necrotic
core-to-lumen dis-
tance at the thinnest
part of fibrous cap
(mm)
0.09 (0.04–0.19) 0.09 (0.03–1.17)
Maximal necrotic
core-to-lumen dis-
tance at the thickest
part of fibrous cap
(mm)
0.73 (0.53–1.20) 0.70 (0.49–1.60)
Values given are medians and ranges. *Mann–Whitney U test plus a-adiameter of fibrous cap between groups (Table 2).
Furthermore, some uncertainty remains concerning
the magnitude of the measures reported in the paper
by Dhume et al.14 For example, in their study, the
average maximum fibrous cap diameter was 2–3-fold
smaller in the symptomatic group than the corre-
sponding minimal fibrous cap diameter in our sampleICA plaque in asymptomatic/symptomatic or unruptured/ruptured
P* Unrupt. (nZ24) Rupt. (nZ14) P*
0.665 6.0 (4.0–13.0) 6.0 (2.0–20.0) 0.950
0.257 2.74 (1.54–4.75) 2.41 (1.58–5.36) 0.254
0.510 0.09 (0.03–0.19 0.08 (0.03–0.17) 0.705
0.795 0.75 (0.50–1.20) 0.68 (0.49–1.60) 0.160
djustment (P!0.05/8Z0.0063 indicates significant findings).
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Table 3. Relationships between the mean number of ‘vital’ smooth muscle cells (SMC) per mm2 fibrous cap, various measures of SMC
apoptosis in ICA plaque and clinical (asymptomatic/symptomatic) or morphological (unruptured/ruptured) features of plaque
instability, respectively
Asympt. (nZ19) Sympt. (nZ19) P* Unrupt. (nZ24) Rupt. (nZ14) P*
Mean number of
SMCs per mm2
fibrous cap, n/mm2
63.33 (11.73–168.40) 39.03 (22.27–182.00) 0.791 57.97 (22.52–168.40) 35.80 (11.73–182.00) 0.505
Total number of
TUNEL pos. SMCs
per plaque, n
2.00 (0.00–36.00) 24.00 (0.00–82.00) !0.001 2.50 (0.00–82.00) 22.00 (0.00–54.00) 0.077
Mean number of
TUNEL pos. SMCs
per total plaque
area, n/mm2 * 10K2
0.00 (0.00–3.00) 5.00 (0.00–55.00) !0.001 0.00 (0.00–6.00) 3.00 (0.00–55.00) 0.025
Mean number of
TUNEL pos. SMCs
per fibrous cap area,
n/mm2
0.00 (0.00–1.87) 1.71 (0.00–4.32) !0.001 0.00 (0.00–3.30) 0.66 (0.00–4.04) 0.067
TUNEL pos. SMCs
within fibrous cap
per thousand ‘vital’
SMCs,n/1000
2.19 (0.00–37.19) 37.83 (0.00–256.76) !0.001 3.55 (0.00–256.76) 22.96 (0.00–251.50) 0.117
Values given are medians and ranges. *Mann–Whitney U test plus a-adjustment (P!0.05/10Z0.005 indicates significant findings).
F. Trostdorf et al.534(see Table 2).14 Fibrous cap morphometry did not
reveal any significant differences between ruptured
and unruptured plaques either, indicating that fibrous
cap thinning does not invariably precede plaque
rupture.
A methodical limitation of our study was that in
ruptured plaques the minimal necrotic core to lumen
distance might only be an approximate value, because
the actual minimal distance immediately before
rupture might have been even smaller. However, the
similar fibrous cap area in ruptured and unruptured
plaques does not suggest that this was a major source
of bias.
Other mechanisms weakening the viscoelastic and
mechanical properties of the fibrous cap (i.e. degra-
dation of extracellular matrix, decrease in collagen
composition, neovascularization, or water content)
may be important.8,18–20 Unfortunately, we did not
study the composition or mechanical resistance of the
fibrous cap.
Another finding of our study was the considerably
higher number of SMCs undergoing apoptotic cell
death in symptomatic compared to asymptomatic
plaques (Table 3). Apoptotic SMC were almost
exclusively located in the fibrous cap, and there was
no preference for the shoulder regions of the plaque
(see Fig. 2(A) and (B)). In general, this is in line with
previous work fromDhume et al. showing 9.92G0.55%
of SMCs being apoptotic in the fibrous cap in
asymptomatic vs. 23.88G0.8% apoptotic SMCs in the
fibrous cap in symptomatic patients (p!0.05).14
Despite a high rate of apoptosis, we found no
significant relationship between the total number ofEur J Vasc Endovasc Surg Vol 29, May 2005apoptotic SMCs within the fibrous cap and the average
area of the fibrous cap, or the minimal necrotic core-to-
lumen-distance. Furthermore, based on the present
analysis there are no arguments for a substantial loss
of SMC cellularity via apoptosis in the fibrous cap of
symptomatic plaque. This view is supported further
by the finding that plaque rupture was not associated
significantly with SMC apoptosis. In conclusion, our
study does not support the hypothesis that SMC
apoptosis contributes to a loss of SMC cellularity
promoting plaque rupture in high-grade ICA disease.
It is possible that the high SMC turnover in the
symptomatic plaque is maintained by cytokines and
growth factors produced by inflammatory cells
located at the border zone between the necrotic core
and the fibrous cap.21 Furthermore, there are some
data supporting the view that high SMC turnover may
be associated with a change of collagen composition
and of extracellular cross-linking,11 but the association
of these mechanisms to plaque rupture has not been
investigated in a clinically relevant human material.
In conclusion, the our findings do not support the
hypothesis that the loss of SMC cellularity and of
fibrous cap volume via SMC apoptosis is a pivotal
prerequisite for plaque rupture in high-grade carotid
stenosis. In contrast, the fibrous cap of symptomatic
carotid plaque was characterized by a nearly 10-fold
higher rate of SMC apoptosis, but this was not
associated with either a reduction of SMC cellularity
of the fibrous cap or by its focal thinning. Other
mechanisms influencing the mechanical properties of
the fibrous cap, rather than quantitative SMC changes,
may predispose to plaque rupture.
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